# OnCo record adcendo (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/adcendo/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "adcendo" ;
  schema:name "Adcendo"@en ;
  schema:description "Adcendo is a Danish company developing antibody-drug conjugates, antibodies that deliver a cell-killing drug straight to cancer cells, against targets few others are pursuing. Its first medicines are in early human trials, including one for soft tissue sarcoma."@en ;
  schema:url <https://onco.cc/companies/adcendo/>, <https://adcendo.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://adcendo.com/>, <https://adcendo.com/adcendo-aps-completes-oversubscribed-135-million-series-b-financing-to-advance-first-in-class-adc-pipeline/>, <https://adcendo.com/adcendo-aps-completes-75-million-series-c-financing-to-continue-advancing-first-and-best-in-class-clinical-adc-pipeline/> ;
  schema:addressCountry "DK" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/tissue-factor/> ;
  onco:trials <https://onco.cc/trials/nct06797999/> .